Streetbeat News

Stock Prices

ATI

Analysts have provided mixed ratings for ATI (NYSE:ATI) over the past three months, with a recent increase in the average 12-month price target to $77.0. The company's financial performance is strong, with notable revenue growth and profitability, but it faces challenges in debt management.

Portfolio Pulse from Benzinga Insights

October 24, 2024 | 12:01 pm

BCYC

Bicycle Therapeutics (NASDAQ:BCYC) has received mixed analyst ratings, with a majority being bullish. The average 12-month price target is $41.82, slightly down from the previous $43.00. The company faces revenue challenges but maintains strong financial metrics like net margin and ROE.

Portfolio Pulse from Benzinga Insights

October 24, 2024 | 12:00 pm

WSC

Analysts have provided mixed ratings for WillScot Holdings (NASDAQ:WSC) over the past three months, with a decline in the average 12-month price target. The company's financial metrics, such as net margin and return on equity, are below industry standards, and it has a high debt-to-equity ratio. These factors may influence investor sentiment.

Portfolio Pulse from Benzinga Insights

October 24, 2024 | 12:00 pm

MRNS

Marinus Pharmaceuticals has had its shares halted pending news, which could indicate significant developments for the company. Investors should stay alert for updates.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2024 | 12:00 pm

TYRA

Tyra Biosciences shares are trading higher following the announcement of a conference call and webcast to discuss interim clinical results of TYRA-300 from the SURF301 Phase 1/2 study in metastatic urothelial cancer.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2024 | 12:00 pm

RCUS

Arcus Biosciences shares rose following the presentation of clinical activity data for casdatifan at the 2024 EORTC-NCI-AACR Symposium.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2024 | 11:58 am

VKTX

Viking Therapeutics shares rose following the announcement of better-than-expected Q3 EPS results.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2024 | 11:57 am

FDX

UPS

FedEx shares are trading higher in sympathy with UPS, which rose after reporting Q3 earnings.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2024 | 11:56 am

CLS

Celestica shares rose following the company's announcement of better-than-expected Q3 financial results and Q4 revenue guidance that surpassed estimates.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2024 | 11:55 am

MRNS

Trading for MRNS was halted at 7:55 a.m. ET due to pending news. This indicates that significant information regarding the company is expected to be released soon, which could impact its stock price.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2024 | 11:55 am